GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IMRIS Inc (GREY:IMRSQ) » Definitions » ROCE %

IMRIS (IMRSQ) ROCE % : -60.53% (As of Dec. 2014)


View and export this data going back to 2010. Start your Free Trial

What is IMRIS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IMRIS's annualized ROCE % for the quarter that ended in Dec. 2014 was -60.53%.


IMRIS ROCE % Historical Data

The historical data trend for IMRIS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMRIS ROCE % Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
ROCE %
Get a 7-Day Free Trial Premium Member Only -1.42 -21.07 -40.12 -75.03 -55.89

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -122.32 -50.31 -51.45 -72.55 -60.53

IMRIS ROCE % Calculation

IMRIS's annualized ROCE % for the fiscal year that ended in Dec. 2014 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2014 )  (A: Dec. 2013 )(A: Dec. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2014 )  (A: Dec. 2013 )(A: Dec. 2014 )
=-25.568/( ( (85.561 - 27.835) + (65.484 - 31.723) )/ 2 )
=-25.568/( (57.726+33.761)/ 2 )
=-25.568/45.7435
=-55.89 %

IMRIS's ROCE % of for the quarter that ended in Dec. 2014 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2014 )  (Q: Sep. 2014 )(Q: Dec. 2014 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2014 )  (Q: Sep. 2014 )(Q: Dec. 2014 )
=-21.34/( ( (59.532 - 22.787) + (65.484 - 31.723) )/ 2 )
=-21.34/( ( 36.745 + 33.761 )/ 2 )
=-21.34/35.253
=-60.53 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2014) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMRIS  (GREY:IMRSQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


IMRIS ROCE % Related Terms

Thank you for viewing the detailed overview of IMRIS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


IMRIS (IMRSQ) Business Description

Traded in Other Exchanges
N/A
Address
100-1370 Sony Place, Winnipeg, MB, CAN, R3T 1N5
IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.

IMRIS (IMRSQ) Headlines

No Headlines